Hint mode is switched on Switch off
For swift navigation between sections

InMode

PDF download

Choose all Reset all
Download Cancel
Organization name
InMode Ltd
Country name
USA
Country of registration
Israel
Industry
Medical Devices
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

InMode Ltd. is a leading global provider of innovative and award winning medical technologies that focuses on well-being and life-changing results. InMode develops, manufacturers, and markets platforms that harness novel radio-frequency (RF) based technology that strives to enable new emerging minimally-invasive procedures and improve existing surgical procedures. InMode has leveraged its medically-accepted RF technologies to offer a comprehensive line of platforms that will enable us to capitalize on a multi-billion dollar market opportunity across several categories of surgical specialty such as plastic surgery, gynecology, dermatology, ENT’s and ophthalmologists.

Awards

News

07/11/2025 Golden Entertainment's Financial Performance and Market Resilience
05/11/2025 InMode Ltd. (NASDAQ: INMD) Surpasses Earnings and Revenue Estimates
10/07/2025 InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375M
28/05/2025 InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025
06/03/2025 InMode Responds to Doma Perpetual's Letters
All organization news

Documentation

IFRS/US GAAP reports

2025
IV q eng
2024
IV q eng
2023
IV q eng
2022
IV q eng
2021
IV q eng
2020
IV q eng
2019
IV q eng
Show more Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    3845 ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001742692
Registration is required to get access.